BIOMAT Database Logo BIOMAT Database Logo

[Immunological status and the results of levamisole treatment of patients with lymphocytic leukemia]. 1980

H Zywicka-Lopaciuk, and L Konopka, and M Karpowicz, and T Sylwestrowicz, and K Maślanka, and E Arczyńska-Brojer, and S Cieśluk, and W Małkowska-Zwierz, and S Pawelski

UI MeSH Term Description Entries
D007136 Immunoglobulins Multi-subunit proteins which function in IMMUNITY. They are produced by B LYMPHOCYTES from the IMMUNOGLOBULIN GENES. They are comprised of two heavy (IMMUNOGLOBULIN HEAVY CHAINS) and two light chains (IMMUNOGLOBULIN LIGHT CHAINS) with additional ancillary polypeptide chains depending on their isoforms. The variety of isoforms include monomeric or polymeric forms, and transmembrane forms (B-CELL ANTIGEN RECEPTORS) or secreted forms (ANTIBODIES). They are divided by the amino acid sequence of their heavy chains into five classes (IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M) and various subclasses. Globulins, Immune,Immune Globulin,Immune Globulins,Immunoglobulin,Globulin, Immune
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D007978 Levamisole An antihelminthic drug that has been tried experimentally in rheumatic disorders where it apparently restores the immune response by increasing macrophage chemotaxis and T-lymphocyte function. Paradoxically, this immune enhancement appears to be beneficial in rheumatoid arthritis where dermatitis, leukopenia, and thrombocytopenia, and nausea and vomiting have been reported as side effects. (From Smith and Reynard, Textbook of Pharmacology, 1991, p435-6) L-Tetramisole,Levotetramisole,Decaris,Dekaris,Levamisole Hydrochloride,Solaskil,Hydrochloride, Levamisole
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012397 Rosette Formation The in vitro formation of clusters consisting of a cell (usually a lymphocyte) surrounded by antigenic cells or antigen-bearing particles (usually erythrocytes, which may or may not be coated with antibody or antibody and complement). The rosette-forming cell may be an antibody-forming cell, a memory cell, a T-cell, a cell bearing surface cytophilic antibodies, or a monocyte possessing Fc receptors. Rosette formation can be used to identify specific populations of these cells. Immunocytoadherence,Formation, Rosette,Formations, Rosette,Immunocytoadherences,Rosette Formations

Related Publications

H Zywicka-Lopaciuk, and L Konopka, and M Karpowicz, and T Sylwestrowicz, and K Maślanka, and E Arczyńska-Brojer, and S Cieśluk, and W Małkowska-Zwierz, and S Pawelski
[Levamisole correction of immunologic disorders in patients with lymphocytic leukemia].
May 1985, Vrachebnoe delo,
H Zywicka-Lopaciuk, and L Konopka, and M Karpowicz, and T Sylwestrowicz, and K Maślanka, and E Arczyńska-Brojer, and S Cieśluk, and W Małkowska-Zwierz, and S Pawelski
[Effect of levamisole on cellular immunity in patients with lymphocytic leukemia].
November 1985, Gematologiia i transfuziologiia,
H Zywicka-Lopaciuk, and L Konopka, and M Karpowicz, and T Sylwestrowicz, and K Maślanka, and E Arczyńska-Brojer, and S Cieśluk, and W Małkowska-Zwierz, and S Pawelski
[Cellular and humoral indicators of the immunomodulating effect of levamisole in patients with lymphocytic leukemia].
December 1985, Vrachebnoe delo,
H Zywicka-Lopaciuk, and L Konopka, and M Karpowicz, and T Sylwestrowicz, and K Maślanka, and E Arczyńska-Brojer, and S Cieśluk, and W Małkowska-Zwierz, and S Pawelski
[Treatment of rheumatoid arthritis with levamisole. Preliminary study of clinical and immunological results].
May 1977, La Nouvelle presse medicale,
H Zywicka-Lopaciuk, and L Konopka, and M Karpowicz, and T Sylwestrowicz, and K Maślanka, and E Arczyńska-Brojer, and S Cieśluk, and W Małkowska-Zwierz, and S Pawelski
[Immunological study and results of treatment by levamisole in 25 atopic patients (author's transl)].
May 1977, Annales de dermatologie et de venereologie,
H Zywicka-Lopaciuk, and L Konopka, and M Karpowicz, and T Sylwestrowicz, and K Maślanka, and E Arczyńska-Brojer, and S Cieśluk, and W Małkowska-Zwierz, and S Pawelski
Burn-induced immunological modifications. Preliminary results with levamisole.
January 1981, Acta chirurgiae plasticae,
H Zywicka-Lopaciuk, and L Konopka, and M Karpowicz, and T Sylwestrowicz, and K Maślanka, and E Arczyńska-Brojer, and S Cieśluk, and W Małkowska-Zwierz, and S Pawelski
[Levamisole in autoimmune complications of chronic lymphocytic leukemia].
January 1989, Sovetskaia meditsina,
H Zywicka-Lopaciuk, and L Konopka, and M Karpowicz, and T Sylwestrowicz, and K Maślanka, and E Arczyńska-Brojer, and S Cieśluk, and W Małkowska-Zwierz, and S Pawelski
[Immunological aspects of lymphocytic leukemia].
August 1976, Sovetskaia meditsina,
H Zywicka-Lopaciuk, and L Konopka, and M Karpowicz, and T Sylwestrowicz, and K Maślanka, and E Arczyńska-Brojer, and S Cieśluk, and W Małkowska-Zwierz, and S Pawelski
[Preliminary evaluation of immunological function in patients with acute lymphocytic leukemia].
June 2010, Zhongguo shi yan xue ye xue za zhi,
H Zywicka-Lopaciuk, and L Konopka, and M Karpowicz, and T Sylwestrowicz, and K Maślanka, and E Arczyńska-Brojer, and S Cieśluk, and W Małkowska-Zwierz, and S Pawelski
[Immunological status of monkeys during acclimatization and its correction with levamisole].
March 1986, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
Copied contents to your clipboard!